These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inverse agonism at dopamine D2 receptors. Haloperidol-induced prolactin release from GH4C1 cells transfected with the human D2 receptor is antagonized by R(-)-n-propylnorapomorphine, raclopride, and phenoxybenzamine. Nilsson CL; Ekman A; Hellstrand M; Eriksson E Neuropsychopharmacology; 1996 Jul; 15(1):53-61. PubMed ID: 8797192 [TBL] [Abstract][Full Text] [Related]
4. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049 [TBL] [Abstract][Full Text] [Related]
5. Distinct guanine nucleotide binding protein alpha-subunit receptor coupling in GH cell lines: effects of bromocriptine and hormones on effector enzyme modulation. Johansen PW; Paulssen RH; Bjøro T; Gautvik KM; Gordeladze JO Cell Physiol Biochem; 2001; 11(6):339-52. PubMed ID: 11832659 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats. Mueller GP; Simpkins J; Meites J; Moore KE Neuroendocrinology; 1976; 20(2):121-35. PubMed ID: 958594 [TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptor mediates both inhibitory and stimulatory actions on prolactin release. Chang A; Shin SH; Pang SC Endocrine; 1997 Oct; 7(2):177-82. PubMed ID: 9549043 [TBL] [Abstract][Full Text] [Related]
9. D2 dopamine-receptor-mediated inhibition of proliferation of rat lactotropes in culture is accompanied by changes in cell shape. Arita J; Hashi A; Hoshi K; Mazawa S; Suzuki S Neuroendocrinology; 1998 Sep; 68(3):163-71. PubMed ID: 9734000 [TBL] [Abstract][Full Text] [Related]
10. Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro. Giacomelli S; Palmery M; Romanelli L; Cheng CY; Silvestrini B Life Sci; 1998; 63(3):215-22. PubMed ID: 9698051 [TBL] [Abstract][Full Text] [Related]
11. One minute of bromocriptine irreversibly inhibits prolactin release for hours. Cronin MJ; Evans WS; Thorner MO Eur J Pharmacol; 1984 Mar; 99(1):85-90. PubMed ID: 6723793 [TBL] [Abstract][Full Text] [Related]
12. Slow dissociation of partial agonists from the D₂ receptor is linked to reduced prolactin release. Carboni L; Negri M; Michielin F; Bertani S; Fratte SD; Oliosi B; Cavanni P Int J Neuropsychopharmacol; 2012 Jun; 15(5):645-56. PubMed ID: 21733233 [TBL] [Abstract][Full Text] [Related]
13. Partial dopamine D2 receptor agonists antagonize prolactin-regulating D2 receptors in a transfected clonal cell line (GH4ZR7). Nilsson C; Eriksson E Eur J Pharmacol; 1992 Aug; 218(2-3):205-11. PubMed ID: 1358634 [TBL] [Abstract][Full Text] [Related]
14. Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 clone. Cronin MJ; Perkins SN; Keefer DA; MacLeod RM Mol Cell Endocrinol; 1982 Oct; 28(2):229-46. PubMed ID: 7128925 [TBL] [Abstract][Full Text] [Related]
15. The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cells. Login IS; Trugman JM Neuropharmacology; 1989 Jun; 28(6):647-50. PubMed ID: 2547181 [TBL] [Abstract][Full Text] [Related]
16. Effects of remoxipride and raclopride on prolactin release from clonal pituitary tumour cells. Nilsson CL; Eriksson E Pharmacol Toxicol; 1995 Jan; 76(1):85-8. PubMed ID: 7753765 [TBL] [Abstract][Full Text] [Related]
17. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. Ishibashi M; Yamaji T J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273 [TBL] [Abstract][Full Text] [Related]
18. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats. González LC; Pinilla L; Tena-Sempere M; Aguilar E J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of prolactin release from anterior pituitary lactotrophs in culture by sulfur-containing analogs of dopamine. Ross PC; Burkman AM Proc Soc Exp Biol Med; 1988 May; 188(1):87-91. PubMed ID: 3368483 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland. Burris TP; Stringer LC; Freeman ME Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]